Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 0 | 0 | 0 | 0 | 1,961 |
| Gross Profit | N/A | N/A | 0 | N/A | 1,961 |
| Operating Expenses | 15,847 | 13,780 | 13,362 | 27,781 | 7,219 |
| Operating Income | -15,847 | -13,780 | -13,362 | -27,781 | -5,258 |
| Interest Expense | 0 | 0 | -1 | 110 | 169 |
| Other Income | 35 | 15 | 16 | -772 | -57 |
| Pre-tax Income | -15,812 | -13,765 | -13,345 | -28,663 | -5,484 |
| Income Tax | 154 | 63 | -40 | 37 | 1 |
| Net Income Continuous | -15,966 | -13,828 | -13,305 | -28,700 | -5,485 |
| Minority Interests | -8,342 | -7,605 | -8,116 | -25,558 | -5,485 |
| Net Income | $-7,624 | $-6,223 | $-5,189 | $-3,142 | $N/A |
| EPS Basic Total Ops | -0.31 | -0.29 | -0.27 | -0.16 | N/A |
| EPS Basic Continuous Ops | -0.66 | -0.65 | -1.24 | -1.48 | N/A |
| EPS Diluted Total Ops | -0.31 | -0.29 | -0.27 | -0.16 | N/A |
| EPS Diluted Continuous Ops | -0.66 | -0.65 | -1.24 | -1.48 | N/A |
| EBITDA(a) | $-15,725 | $-13,669 | $-13,249 | $-27,661 | $-5,130 |